New COVID-19 Clinical Guidance Now Available From the ACR!

The ACR has developed new guidance for rheumatology providers on the use of the COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). The recommendations focus on general considerations related to COVID-19 […]

Read More…


COVID-19 Resource: The Centre for Effective Practice

The Centre for Effective Practice has published a helpful resource with information on COVID-19. The content on their website is updated frequently. To access this resource, please visit this link: https://tools.cep.health/tool/covid-19-vaccines/#availability-rollout-and-prioritization-in-ontario […]

Read More…


Canadian Rheumatology Association Position Statement on COVID-19 Vaccination – Updated

The Canadian Rheumatology Association recently updated their position statement on the COVID-19 Vaccination. To review the updated position statement, please visit this link: https://rheum.ca/wp-content/uploads/2021/01/Updated-Position-Statement-on-Covid19-Vaccine_Jan_21.pdf They have also created a Decision Aid pamphlet for […]

Read More…


COVID-19 Vaccine & Recommended Resources

We have updated our COVID-19 Info section to include two new recommended resources: The American College of Rheumatology December 2020 Update The British Society for Rheumatology COVID-19 Vaccine Guidance ACIP COVID Vaccine Recommendation […]

Read More…


Canadian Rheumatology 2020: Workforce and Wellness Survey

Canadian Rheumatology 2020: Workforce and Wellness Survey It has been 5 years since the first national workforce survey and it’s time to check in with rheumatologists across the country. In addition to understanding issues […]

Read More…


Now Accepting 2021 ORA Membership Renewals

The Ontario Rheumatology Association is now accepting online membership renewals. In light of the financial challenges many of us have endured over the last 6 months, we will not be increasing membership fees this year. The […]

Read More…


Transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles Immunization Program

Starting mid-October 2020, the Ontario publicly funded shingles (Herpes Zoster) immunization program will begin to transition to Shingrix® vaccine instead of Zostavax®II vaccine. It is important to note that this is for adults […]

Read More…


Biosimilar Form

With so many new and emerging biosimilars, we have created a simple document that you may find useful. We will update it as new information becomes available.  You may access the form here: […]

Read More…


OHIP Bulletin (Posted on August 7, 2020)

To access the August 7, 2020 OHIP Bulletin, please click on this link: OHIP Bulletin Aug 7 2020 Please also note the following information provided by OMA President Dr. Samantha Hill: Phase I […]

Read More…


Common Questions on E078 Billings

With the recent good news announcement from the OMA on E078, many of you have questions on how to move forward. Dr. Philip Baer has written to the ORA membership to provide some […]

Read More…